Introduction
============

Testosterone has been associated with various health, lifestyle, and physical performance parameters in a variety of populations, inclusive of clinical and active/healthy populations. For example, [@B9] reported favorable relationships of exogenous TES administration on body composition, physical performance and plasma lipids in healthy young men. Additionally, a novel study by [@B11] reported a positive association between basal TES concentration and performance capacity (higher maximal vertical jump, faster 30 m dash and better aerobic performance) in soccer players. While exercise-induced responses of endogenous hormonal concentrations have received considerable attention in the literature, a paucity of cross-sectional studies exists for basal endogenous TES and health and fitness outcomes for young, healthy populations.

Testosterone is known to have significant anabolic effects via nitrogen retention ([@B10]), neuromuscular transmission ([@B61]), and potentiating the effectiveness of other hormones such as growth hormone ([@B25]), which can lead to favorable body composition profiles (increased FFM and decreased FM). Nonetheless, a clear relationship between body composition, strength and TES has yet to be validated with endogenous TES in a normal, heterogeneous, healthy male population. Meanwhile, improved aerobic performance capacity can be observed in men with lower basal TES as demonstrated by [@B11] who showed that in similarly trained athletes, those with lower basal TES performed better on the Cooper's 12-min run. Similarly, reduced basal TES, even as low as subclinical levels, is exhibited in highly aerobically trained individuals ([@B14]). In addition to relationships to physical performance and body composition, TES has also been suggested to be associated with various health outcomes; including blood glucose and lipids, as well as BP, although inconsistent and conflicting observations have been reported ([@B41]; [@B48]; [@B63]; [@B1]). Furthermore, while not always the case, hypogonadism and TES deficiency have been associated with CVD, insulin resistance, diabetes mellitus, and the metabolic syndrome ([@B62]). Thus, higher basal TES concentration would seem to contribute to more favorable blood lipid profiles and glucose concentration as well as healthier BP levels.

While the scope of this study examines endogenous steroid hormones, it is nonetheless important to mention the existence of exogenous steroid hormones, especially the abuse of anabolic-androgenic steroids (AAS), and their profound impact on health. In some diseases, AAS are administered therapeutically, however they are also frequently used in excess to enhance physical performance, and aesthetic purpose ([@B2]; [@B7]; [@B56]). This is not only seen in athletes, but in prepubescent ([@B59]), adolescent ([@B59]; [@B2]; [@B7]) and the general population in fitness centers as well, and has been even considered a "serious public health concern" ([@B56]) and a world-wide pandemic ([@B54]; [@B7]). Whole-body organ damage has been documented from AAS abuse ([@B2]) and is linked to behavioral disorders ([@B7]) and cancer, particularly of the Leydig cells ([@B56]). One of the most frequently abused AASs in the world is Nandrolone, a synthetic derivative of testosterone, actually decreases the production of endogenous testosterone by reducing the conversion of cholesterol to pregnenolone ([@B64]; [@B56]).

With an interplay of factors influencing biological activity of TES, two of these important factors are SHBG, which specifically binds circulating TES, and COR the antagonist to TES. Although SHBG has a crucial influence on circulating bioavailable TES, few studies have considered it as a primary contributor to health status ([@B27]; [@B6]; [@B1]). Nevertheless, stronger associations have been observed between blood lipids and SHBG than with TES ([@B6]). SHBG levels are modulated by sex hormones ([@B3]; [@B6]) and a marked increase is observed in men after the age of 50 ([@B73]; [@B3]). An increase in SHBG following a physical training regimen has been observed in military training studies lasting 8 -- 12 weeks ([@B65]; [@B68]; [@B15]). [@B36] also showed higher SHBG levels in elite soccer players over two seasons when compared to controls. Meanwhile, the catabolic action of COR contributes in an antagonistic fashion to that of TES for muscle tissue remodeling. An inverse relationship has been suggested for COR and aerobic capacity in similarly trained individuals ([@B11]). COR is often used as a marker for over-reaching/overtraining and excessive stress in athletes ([@B43]; [@B36]) and in military training ([@B65]) and a reduction in performance is observed. Evidence of a relationship between elevated COR concentrations and elevated total cholesterol (CHOL) in individuals with CVD, in particular with greater severity of CVD, as well as with moderate CAD, and SBP greater than 160 mmHg ([@B67]; [@B18]; [@B52]), has previously been demonstrated. Whether this relationship is already evident in a young healthy population can provide insight on future health risks.

The importance of studying basal concentrations of endogenous TES, COR, and SHBG resides in their significance in mediating health and fitness outcomes (e.g., [@B50]), and could provide an indication of health risk for future health problems such as CVD and CAD (e.g., [@B62]). Few large-scale population-based studies have adequately examined such relationships. Therefore, the purpose of the present study was to describe the relationship of body composition, cardiovascular (CV) risk factors, and physical fitness profile to basal endogenous steroid hormones (TES and COR) and SHBG to in a large cohort of healthy men. We hypothesized that men with higher basal concentrations of TES would have a healthier body composition, lower CV risk factors and better performance for physical fitness parameters of muscular strength, endurance and agility. In contrast, men with higher basal concentrations of COR would show less desirable body composition, greater CV risk factors and reduced performance for physical performance, with the exception of aerobic fitness.

Materials and Methods {#s1}
=====================

Participants
------------

The present study was a cross-sectional study consisting of young Finnish men. Inclusion criteria consisted of all reservists who were called up to military refresher training and deemed physically fit to participate by a physician (see Protocol, below). A total of 1155 reservists were called up, in a total of 8 testing sessions. 846 men between the ages of 18 and 48 years (25.1 ± 4.7 years; height 1.8 ± 0.1 m; body mass 80.5 ± 13.5 kg) volunteered to be a part of the study group (see **Table [1](#T1){ref-type="table"}**). Exclusion criteria included reporting any of the following: respiratory or CVD, diseases or injuries causing restrictions for physical activity, chronic musculoskeletal disease or injury, blood pressure medication, infection during the last 2 weeks, chest pain during exercise, and being female. Prior physical activity level was surveyed by a questionnaire and has been reported in a previous paper ([@B69]). They categorized physical activity into leisure-time, commuting, and occupational activity and reported the percentage of participants who responded to have low, moderate and high levels for each category. 29.7, 39.8, and 30.4% of participants self-reported leisure-time physical activity as low, moderate and high, respectively. Data was analyzed for valid cases, see results tables for respective *N* included in individual analyses. Participants were not undergoing specific military training prior to the study. Participants provided written informed consent. This study was approved by the Ethical Committee of the Central Finland Health Care District, Jyväskylä, Finland, and the Surgeon General of the Finnish Defence Forces.

###### 

Descriptive data of study population.

                                     *N*   Mean     *SD*    IQR      
  ---------------------------------- ----- -------- ------- -------- --------
  Physical characteristics                                           
   Age (years)                       846   25       5       22       26
   Height (m)                        844   1.80     0.06    1.76     1.84
   Body mass (kg)                    842   80.6     13.4    71.7     87.8
  Hormones and binding protein                                       
   TES (nmol^.^L^-1^)                827   17.4     5.0     13.7     20.3
   EFT (nmol^.^L^-1^)                825   280.39   85.96   216.70   330.32
   COR (nmol^.^L^-1^)                827   488      124     403      571
   SHBG (nmol^.^L^-1^)               825   34.0     12.3    25.5     40.9
  Body composition                                                   
   BMI (kg^.^m^-2^)                  842   24.8     3.8     22.3     26.8
   WC (cm)                           844   86.3     10.4    79.0     91.3
   FFM (kg)                          839   65.4     7.4     60.3     70.0
   %BF                               839   17.9     7.2     12.6     22.1
  Cardiovascular health                                              
   HR (bpm)                          814   66       12      58       74
   SBP (mmHg)                        844   123      12      115      130
   DBP (mmHg)                        844   77       9       71       82
   Glucose (mmol^.^L^-1^)            826   5.40     0.41    5.14     5.63
   CHOL (mmol^.^L^-1^)               829   4.5      0.9     3.9      5.0
   Triglycerides (mmol^.^L^-1^)      829   1.03     0.53    0.68     1.20
   HDL (mmol^.^L^-1^)                829   1.49     0.36    1.25     1.69
   LDL (mmol^.^L^-1^)                826   2.43     0.63    1.97     2.79
   CHOL/HDL                          829   3.2      1.0     2.5      3.7
  Relative physical fitness                                          
   Agility run (s)                   812   6.07     0.44    5.75     6.31
   Sit-ups (reps^.^min^-1^)          792   38       10      31       45
   Push-ups (reps^.^min^-1^)         777   29       13      20       37
   Squats (reps^.^min^-1^)           773   44       9       39       50
   LP~max~ (N^.^kg^-1^)              809   40.0     11      30       42
   BeP~max~ (N^.^kg^-1^)             821   11       3       10       13
   VO~2peak~ (ml^.^kg^-1.^min^-1^)   787   41.6     8.1     36.0     46.9
  Absolute physical fitness                                          
   LP~max~ (N)                       812   2939     871     2371     3372
   BeP~max~ (N)                      823   900      199     759      1005
   VO~2peak~ (L^.^min^-1^)           783   3.30     0.58    2.87     3.69

Relative physical fitness is relative to the participants' body mass in kg. Note that agility run, sit-ups, push-ups and squats are considered relative to body mass as the subject is required to move their body mass to complete the task. Means and standard deviation (SD) are presented. IQR, Interquartile Range; Q1, First quartile; Q3, Third quartile.

Protocol
--------

Participants arrived at their respective region's garrison by 1400 h on the day prior to their specified testing date. Upon arrival, participants underwent a medical examination by a physician, as pre-screening for participation in the study. A familiarization information session detailed the purpose of the study, and explained the protocol as well as the measurements. Participants also completed a Physical Activity, Health and Lifestyle Questionnaire during the information session. Participants were divided into groups of 10, within which they would complete the testing session the following day; the first group commencing at 0550 h, subsequent groups at 10-min intervals. The timeline for a testing session is outlined in **Figure [1](#F1){ref-type="fig"}**. Participants underwent an overnight fast, with unrestricted water ingestion for 12 h prior to obtaining a fasting blood sample. Participants were subsequently provided a light breakfast which included a standardized serving of 1100 kcal containing 60% carbohydrates, 15% protein, 25% fat ([@B70]), and with a maximum of one serving of a caffeinated drink, prior to exercise testing.

![Timing and organization of the research study protocol that occurred during 8 separate testing sessions. This includes the approximate timing of events on arrival and testing day for the military training refresher course and study participation. Arrival day included medical screening, and a familiarization session. Testing day has the approximate timing of when testing started, as well as the order of exercise testing.](fphys-09-01005-g001){#F1}

Blood Samples and Analysis
--------------------------

A venous blood sample was taken from the antecubital vein with the subject in a supine position. Terumo VenoSafe^TM^ (Terumo Europe, Leuven, Belgium) blood sampling method was used, and aliquoted into 5 collection tubes. K~2~EDTA whole blood collection tubes were immediately centrifuged and analyzed at the collection site. Serum samples were allowed to coagulate according to manufacturer's instructions and were subsequently centrifuged. Plasma glucose and serum CHOL, HDL, and triglycerides were analyzed the following day.

Serum total TES, SHBG, and COR were analyzed by Immulite 1000 (Siemens Healthcare Diagnostics Products Ltd., Gwynedd, United Kingdom). The sensitivity for these assays were 0.5, 0.2, and 5.5 nmol^.^L^-1^ for TES, SHBG, and COR, respectively. Intra- and inter-assay coefficients of variance were 5.7 and 13.2% for TES, 2.4 and 6.7% for SHBG, and 4.6 and 7.6% for COR, respectively. Time of measurement for blood sampling was standardized so that the analyses represented morning fasting hormonal concentrations. Morning samples were taken between 0550 and 0800 h as TES peaking occurs approximately between 0600 and 0800 h ([@B26]), and COR peak between 0400 and 0800 h ([@B72]; [@B39]). Free TES was determined statistically as EFT when TES ≥ 5 nmol^.^L^-1^ using the model 2 empirical equation by [@B47], as follows:
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where TT represents blood total TES.

Body Composition
----------------

Anthropometric measurements including height, body mass, and WC, were measured with a stadiometer, commercial scale, and tape measure, respectively. BMI was calculated from height and weight. Body composition analysis for %BF and FFM were estimated via bioelectrical impedance analysis (BIA) (Inbody720, Seoul, Korea). This device has previously been shown to have high test-retest reliability (ICC = 0.9995) ([@B24]).

Cardiovascular Risk Factors
---------------------------

Resting HR was measured using a monitor (Suunto Smart Belt, Finland), and later analyzed using Polar Precision Performance software (SW 4.03.043 Polar, Kempele), with the subject lying supine for 5 min. Mean resting HR was taken over the last 3 min. BP was measured twice using an automatic brachial cuff (Omron M6 Comfort, Omron Healthcare Europe B.V. Kruisweg 577--2132 NA, Hoofddorp, The Netherlands) in a seated position at 1--2 min intervals. Mean BP is reported. Blood lipids, including serum CHOL, triglycerides, HDL, and plasma glucose, were analyzed by Konelab^TM^ 20 XTi (Thermo Fisher Scientific Oy, Vantaa, Finland). The reportable range for CHOL, triglycerides, and HDL assays were 0.1 -- 15, 0.09 -- 11, and 0.04 -- 2.84 mmol^.^L^-1^, respectively. Intra- and inter-assay coefficients of variance were 1.1 and 2.1% for CHOL, 1.0 and 3.8% for triglycerides, and 0.5 and 7.6% for HDL, respectively. LDL was calculated using the [@B21] equation. Sensitivity and intra- and inter-assay coefficients of variance for glucose were 0.1 mmol^.^L^-1^, 1.0 and 2.0%, respectively.

Physical Fitness
----------------

Standardized testing procedures were implemented for physical fitness testing in an attempt to minimize inter-rater and inter-session variability. Experienced military personnel and individuals with a major in sport and exercise testing assessed all physical fitness parameters. Testing occurred in large sports halls at military sites with ambient temperature maintained between 20 and 22°C.

Maximal isometric strength testing consisted of maximal bilateral leg press (LP~max~) and bench press (BeP~max~) exercises. Leg and bench press trials were performed on an isometric electromechanical dynamometer. LP~max~ was completed in a seated position with a knee angle of 107° ([@B33]). For BeP~max~, the subject was lying supine with their back flat on a bench, and feet flat on the floor. The shoulder and elbow joints were positioned at 90°. LP~max~ and BeP~max~ trials were preceded by two submaximal trials (first 50% of individual maximum, second almost maximal effort) as a familiarization and warm-up. Participants were instructed to produce maximal force as quickly as possible, and maintain it for about 3 s. Three maximal trials were performed for both the LP~max~ and BeP~max~ exercises, with 30 s recovery between trials. Standardized motivation was given by testing personnel to each subject to encourage maximal effort. Participants were monitored closely for proper technique; trials performed incorrectly were discarded. Isometric strength outputs were collected at a sampling frequency of 1 kHz and analyzed using Signal 2.16 software.

The figure-eight agility run involved a figure-eight circuit with two pylons at a distance of 10 m apart ([@B66]). Each subject had one familiarization trial, followed by two maximal attempts. Test time was measured using photocells (Newtest Powertimer, Newtest Oy, Oulu, Finland) that automatically recorded time to completion.

Maximal aerobic capacity was determined using a graded, multistage, maximal test to volitional fatigue on a cycle ergometer (Ergoline 800S, Ergoselect 100K, Ergoselect 200K, Bitz, Germany). The initial workload was set at 50 W, with an increase of 25 W every 2 min. The test was stopped either at volitional fatigue, or if the subject was unable to keep a pedaling cadence between 60 -- 90 rpm. HR was measured throughout the maximal test using a Polar Vantage NV or S610, S710 or S810 HR monitor (Polar, Kempele, Finland) and analyzed using MILFIT 4 (Aino Active, Helsinki, Finland) software ([@B57]).

Muscular endurance testing involved push-ups, sit-ups, and repeated squats. Participants completed as many repetitions as possible in 60 s for each exercise. There was a recovery of 5 min between tests. Standardized positioning was used for each exercise, described elsewhere ([@B19]; [@B46]). Trials performed with incorrect technique were not counted.

Statistical Analysis
--------------------

Separate stepwise regression analyses were used to predict each hormone (TES, EFT, COR) and SHBG. Predictor variables were clustered in the following four categories: (1) body composition (BMI, WC, FFM, and %BF); (2) CV risk factors (HR, SBP, DBP, glucose, CHOL, triglycerides, HDL, LDL, CHOL/HDL); (3) relative (rel) physical fitness (agility run, sit-ups, push-ups, repeated squats, relLP~max~, relBeP~max~, relVO~2peak~), where relLP~max~, relBeP~max~, and relVO~2peak~ are relative to body mass; and (4) absolute physical fitness (LP~max~, BeP~max~, VO~2peak~). Multiple comparison bias was addressed using a family-wise error correction strategy. Given that four stepwise regression calculations were conducted within each family of independent variables, the threshold for including an independent variable within the prediction equation was adjusted to be *p* = 0.05/4 = 0.0125, and the threshold for statistical significance of each model was similarly adjusted to be *alpha* = 0.0125. Normality was tested using Kolmogorov--Smirnov test and histograms. When appropriate, data was transformed into natural logarithm (ln) to improve normality. This was done for TES, EFT, COR, SHBG, triglycerides, relLP~max~, relBeP~max~, LP~max~ and BeP~max~. Descriptive statistics (mean ± SD, interquartile range: Q1, Q3) for all variables were calculated. Statistical analysis was performed using SPSS (IBM SPSS for Windows Version 19.0.0).

Results
=======

Descriptive data of the physical characteristics of the participants, as well as hormonal and SHBG concentrations, and the variables included in the four independent grouping categories: (1) body composition; (2) CV risk factors; (3) relative physical fitness; and (4) absolute physical fitness, are shown in **Table [1](#T1){ref-type="table"}**.

All hormones and SHBG (*F*~2,818~ = 71.839, *p* \< 0.001; *F*~2,816~ = 50.016, *p* \< 0.001; *F*~1,820~ = 191.408, *p* \< 0.001; *F*~1,824~ = 23.304, *p* \< 0.001, for TES, EFT, SHBG and COR, respectively) were related to body composition variables. **Table [2](#T2){ref-type="table"}** displays the hierarchical regression models for body composition variables when related to TES, EFT, SHBG and COR. WC and %BF were inversely associated with concentrations of TES, and WC inversely with EFT concentrations. FFM was positively associated with EFT concentration. Endogenous TES explained 14.7% of the variation in WC and %BF, while EFT concentration explained 10.7% of the variation in WC and FFM. SHBG concentration was inversely associated with BMI, which explained 18.9% of the variation. Finally, COR and WC were inversely associated, although only explaining 2.6% of the variation.

###### 

Hierarchical regression models for the prediction of endogenous steroid hormones and SHBG, with body composition variables.

                     lnTES               lnEFT               lnSHBG              lnCOR                                                                             
  ------------------ ------------------- ------------------- ------------------- ------------------ ---- ------------ ---------- ---- ------------ ---------- ---- ------------
  Body Composition   R^2^~adj~ = 14.7%   R^2^~adj~ = 10.7%   R^2^~adj~ = 18.8%   R^2^~adj~ = 2.6%                                                                  
  Variable           N = 821             N = 819             N = 822             N = 826                                                                           
                                                                                                                                                                   
                     **Beta**                                ***p***             **Beta**                ***p***      **Beta**        ***p***      **Beta**        ***p***
                                                                                                                                                                   
  BMI                                    NS                                                         NS                -0.435          \<0.001^∗^              NS   
  WC                 -0.242                                  \<0.001^∗^          -0.388                  \<0.001^∗^              NS                -0.166          \<0.001^∗^
  FFM                                    NS                                      0.129                   0.002^∗^                NS                           NS   
  %BF                -0.164                                  0.003^∗^                               NS                           NS                           NS   

R

2

adj

, adjusted R squared; Beta, standardized regression coefficient;

∗

statistically significant, p

in

\< 0.0125; NS, non-significant.

All hormones and SHBG (*F*~3,787~ = 28.866, *p* \< 0.001; *F*~4,784~ = 21.295, *p* \< 0.001; *F*~3,819~ = 51.262, *p* \< 0.001; *F*~3,791~ = 24.350, *p* \< 0.001, for TES, EFT, SHBG and COR, respectively) were related to CV risk factors. **Table [3](#T3){ref-type="table"}** displays the hierarchical regression models for CV risk factors when related to TES, EFT, SHBG and COR. Inverse associations of CHOL/HDL ratio, HR, and glucose, were observed with concentrations of TES and EFT. EFT also had a positive association with triglycerides. TES and EFT explained 9.6 and 9.3% of the variation in CV risk factors, respectively. SHBG was inversely associated with triglycerides and SBP, and positively associated with HDL, explaining 15.5% of the variation. COR was positively associated with SBP, HDL, and HR, explaining 8.1% of the variation.

###### 

Hierarchical regression models for the prediction of endogenous steroid hormones and SHBG, with cardiovascular risk factors.

                    lnTES              lnEFT              lnSHBG              lnCOR                                                                             
  ----------------- ------------------ ------------------ ------------------- ------------------ ---- ------------ ---------- ---- ------------ ---------- ---- ------------
  Cardiovascular    R^2^~adj~ = 9.6%   R^2^~adj~ = 9.3%   R^2^~adj~ = 15.5%   R^2^~adj~ = 8.1%                                                                  
  Risk Factor       N = 791            N = 789            N = 823             N = 795                                                                           
                                                                                                                                                                
                    **Beta**                              ***p***             **Beta**                ***p***      **Beta**        ***p***      **Beta**        ***p***
                                                                                                                                                                
  HR                -0.134                                \<0.001^∗^          -0.138                  \<0.001^∗^              NS                0.101           0.004^∗^
  SBP                                  NS                                                        NS                -0.096          0.003^∗^     0.196           \<0.001^∗^
  DBP                                  NS                                                        NS                           NS                           NS   
  Glucose           -0.113                                0.001^∗^            -0.116                  0.001^∗^                NS                           NS   
  CHOL                                 NS                                                        NS                           NS                           NS   
  lnTriglycerides                      NS                                     0.177                   \<0.001^∗^   -0.291          \<0.001^∗^              NS   
  HDL                                  NS                                                        NS                0.158           \<0.001^∗^   0.169           \<0.001^∗^
  LDL                                  NS                                                        NS                           NS                           NS   
  CHOL/HDL          -0.200                                \<0.001^∗^          -0.262                  \<0.001^∗^              NS                           NS   

R

2

adj

, adjusted R squared; Beta, standardized regression coefficient;

∗

Statistically significant, p

in

\< 0.0125.

All hormones and SHBG (*F*~3,752~ = 28.209, *p* \< 0.001; *F*~2,780~ = 30.838, *p* \< 0.001; *F*~2,761~ = 46.825, *p* \< 0.001; *F*~2,760~ = 14.277, *p* \< 0.001, for TES, EFT, SHBG and COR, respectively) were related to relative physical fitness, but not with absolute fitness, except for SHBG (*F*~1,744~ = 6.459, *p* = 0.008). **Table [4](#T4){ref-type="table"}** displays the hierarchical regression models for relative physical fitness variables when related to TES, EFT, SHBG, and COR. Greater concentrations of TES and EFT were associated with faster agility run time and greater relative BeP~max~, while relative VO~2peak~ also had a positive association with TES. SHBG was positively associated to relative VO~2peak~ and relative BeP~max~, explaining 10.7% of the variation. COR was also inversely associated with agility run and positively associated with relative VO~2peak~, but only explaining 3.4% of the variation. TES, EFT and COR were not indicative of absolute physical fitness, while SHBG only explained 0.7% of variation (absolute BeP~max~: Beta = --0.093, *p* = 0.011).

###### 

Hierarchical regression models for the prediction of endogenous steroid hormones and SHBG, with relative physical fitness variables.

                              lnTES              lnEFT              lnSHBG              lnCOR                                                                                   
  --------------------------- ------------------ ------------------ ------------------- ------------------ ---- ------------ ---------- ------------ ---------- ---------- ---- ---------
  Relative Physical Fitness   R^2^~adj~ = 9.8%   R^2^~adj~ = 7.1%   R^2^~adj~ = 10.7%   R^2^~adj~ = 3.4%                                                                        
  Variable                    N = 756            N = 783            N = 764             N = 763                                                                                 
                                                                                                                                                                                
                              **Beta**                              ***p***             **Beta**                ***p***      **Beta**                ***p***    **Beta**        ***p***
                                                                                                                                                                                
  Agility run                 -0.139                                0.001^∗^            -0.179                  \<0.001^∗^              NS                      -0.095          0.016
  Sit-ups                                        NS                                                        NS                           NS                      NS              
  Push-ups                                       NS                                                        NS                           NS                                 NS   
  Squats                                         NS                                                        NS                           NS                                 NS   
  lnLP~max~                                      NS                                                        NS                           NS                                 NS   
  lnBeP~max~                  0.120                                 0.003               0.139                   \<0.001^∗^   0.110                   0.004^∗^              NS   
  VO~2peak~                   0.144                                 \<0.001^∗^                             NS                0.268      \<0.001^∗^   0.130      0.001^∗^        

Relative physical fitness is relative to the participants' body mass in kg. Note that agility run, sit-ups, push-ups and squats are considered relative to body mass as the subject is required to move their body mass to complete the task; R

2

adj

,

adjusted R squared; Beta, standardized regression coefficient;

∗

Statistically significant, p

in

\< 0.0125; NS, non-significant.

Discussion
==========

The main findings of the present study demonstrate that favorable body composition, lower CV risk factors, and greater maximal aerobic capacity were associated with higher concentrations of basal endogenous TES, EFT, and SHBG in young healthy men. A noteworthy finding was that SHBG might also play a role as a health biomarker in addition to acting as a binding protein.

Significant stepwise regression models were observed for TES, EFT, SHBG, and COR with body composition variables. WC exhibited inverse associations with all of TES, EFT, and COR concentrations. Recently, more attention has been given to the crucial implication that WC has on cardiometabolic health risks. Although BMI is used in standard practice to categorize individuals at an elevated health risk, [@B38] presented evidence that WC is a better indicator of cardiometabolic health risk than BMI. Meanwhile, [@B42] reported that in the identification of individuals with cardiometabolic risk, including CHD and diabetes, WC is a stronger predictor than BMI. The present data revealed that body fat distribution (i.e., WC), was lower in men with higher concentrations of endogenous TES, EFT, and COR, yet BMI was not. Interestingly, a meta-analysis by [@B13] reported that in individuals with hypogonadism, TES supplementation led to weight loss, including a one-point reduction in BMI and a 6 cm loss in WC. In the present study, TES also had a significant inverse relationship with %BF. Previous studies have reported similar relationships between basal total TES and free TES concentrations to FM ([@B4]; [@B58]), while negative associations observed between TES and adiposity are generally seen with central adiposity ([@B40]). A meta-analysis of 59 studies revealed a pooled effect size significant reduction of FM, with an equal and opposite increase in lean mass, with TES supplementation ([@B12]). Based on these findings, visceral and abdominal body fat deposition and quantity are associated with circulating basal endogenous TES, EFT, and COR concentrations. This pattern of central adiposity and concentration of circulating sex steroids has also been reported in a population of healthy non-obese women ([@B50]). Whether basal hormones or current body composition drive this relationship is uncertain with the available data.

The known anabolic effect of TES on skeletal muscle growth suggests that a positive relationship exists between FFM and TES ([@B8]; [@B10]; [@B37]; [@B4]). This is particularly evident in pubertal boys, where increases in TES and lean mass occur in parallel ([@B71]). [@B71] has shown a positive association between free TES and lean mass, as well as with muscle cross sectional area in both the radius and tibia, throughout various stages of puberty. Interestingly, this was not reflected in the present results for TES in young adult men. A study by [@B23] also reported that total TES and free TES had no association to lean mass, yet were significantly inversely correlated with adiposity, as was evident in the current results. Further, the participants in our study belonged to a group of healthy eugonadal men, which is in contrast to other studies that examine specific populations (i.e., hypogonadal, elderly) or use of exogenous TES ([@B8], [@B10]; [@B37]; [@B4]) to demonstrate the positive relationship between FFM and TES.

Sex hormone-binding globulin explained 18.8% of the variation in BMI, which was the largest standardized regression coefficient. This association may indicate that SHBG, although its primary role is its function as a binding protein for TES and other sex steroids in circulation, could also have a more direct function in affecting body composition. While it has been shown that with an increase in FM and insulin serum levels, SHBG concentration is decreased ([@B40]), the biological mechanisms by which this occurs are yet to be determined. Although SHBG is regarded as a binding protein rending SHBG-bound-TES in circulation inactive, even SHBG-bound-TES can have downstream effects via a second messenger by activation of cyclic AMP ([@B55]). There are two binding sites on SHBG, one for steroids, and the other that binds a membrane receptor. When SHBG first interacts with its membrane receptor (e.g., androgen receptor) and then a steroid (e.g., TES, dihydrotestosterone, estradiol) binds to its other receptor ([@B55]), it allows the steroid to exert its effect on the cell without having to enter the cell itself. [@B55] demonstrated this effect in human prostate explants by initiating a downstream secretion of prostate specific antigen when SHBG was first bound to its membrane androgen receptor and then estradiol was introduced into the tissue. Perhaps when SHBG concentrations are reduced, this type of sequence of events does not occur sufficiently, thereby reducing the downstream effects and resulting in increased FM and circulating insulin, ultimately affecting body composition.

When regarding the body composition parameters of BMI, %BF and WC, inverse associations were present for TES, EFT and COR to WC, with TES to %BF, and SHBG to BMI. Importantly, these three parameters (BMI, %BF, WC) are all associated with the prevalence of obesity, the development of the metabolic syndrome ([@B6]), and diabetes mellitus ([@B20]). Obesity has been shown to result in the development of insulin resistance and impaired glucose tolerance, as well as increased insulin production from pancreatic cells ([@B20]; [@B22]). These adverse health outcomes result in increased circulating insulin. Insulin has been reported to inhibit SHBG production by hepatoma cells *in vitro* ([@B53]; [@B22]), suggesting that insulin may be an important regulating factor for SHBG *in vivo* ([@B53]). Furthermore, due to an inhibition of SHBG from elevated insulin, a reduced SHBG concentration in circulation could further inhibit TES secretion via androgen feedback mechanisms on the hypothalamic-pituitary-gonadal axis ([@B22]). This would exacerbate the situation, as a reduction in TES and SHBG would further contribute to a less favorable body composition.

The results of the present study show an association of resting CV risk factors to basal TES, EFT, SHBG and COR concentrations. In accordance with previous studies ([@B27]; [@B6]; [@B1]), an inverse relationship was observed between SHBG and triglycerides. In the study by [@B27], SHBG was the best predictor of triglycerides (*R^2^* = 17%), also the case in our regression analysis model (β = --0.291, *p* \< 0.001). Although no associations were observed between TES and triglycerides, a positive association was seen between EFT and triglycerides. [@B27] reported that the free androgen index had a positive association with triglycerides. These results are in accordance with previous findings that free androgens are associated with an atherogenic lipid profile ([@B27]; [@B6]). The importance of the role of SHBG with triglycerides is likely due to its regulation of bioavailable TES. While free androgens have been associated with an atherogenic lipid profile, a high concentration of SHBG works in an atheroprotective manner to reduce the amount of free androgens in circulation. As [@B6] described, the evaluation of total TES might be misleading by demonstrating both an atherogenic (e.g., free TES) and atheroprotective (e.g., SHBG-bound) effect. Thereby, the measurement of SHBG could be a better indicator of the lipid profile.

A few studies ([@B27]; [@B6]; [@B1]) have observed a positive association between TES and SHBG to HDL. [@B27] reported that SHBG was the main predictive variable of HDL (*R^2^* = 12%). The results of the present study demonstrated that SHBG was predictive of HDL (β = 0.158, *p* \< 0.001). With these findings for triglycerides and HDL, we can reasonably postulate that SHBG should not simply be considered as a binding protein for TES, but as [@B6] suggested, it should be considered as a one of the contributors to the hormonal regulation of the blood lipid profile, although mechanisms by which this occurs are not yet evident. The association seen with SHBG and HDL might be as a result of its down-stream effect on hepatic lipase ([@B6]). As free androgens stimulate hepatic lipase activity ([@B60]; [@B51]), and increased hepatic lipase activity results in a reduction of HDL ([@B51]), the strong binding affinity of SHBG to TES would result in a lower amount of free TES, thereby dampening the stimulation of hepatic lipase and consequently attenuating HDL catabolism resulting in higher circulating HDL.

Fasting blood glucose levels have been reported to be higher in men with lower TES concentrations ([@B5]; [@B32]; [@B48]). Meanwhile, [@B32] observed an inverse partial correlation (--0.18, *p* \< 0.05) between free TES and glucose, 2 h after a 75 g glucose load, but not with fasting glucose, and no relationship between TES and glucose. Similarly, inverse associations with TES and free TES with fasting glucose were evident in our results. Of particular interest, TES supplementation in hypogonadal men is beneficial for their glycometabolic profile, specifically on glycaemia and insulin sensitivity ([@B12]). This effect however, is more pronounced in younger men and men with metabolic disturbances ([@B12]). This shows that TES plays a role in glucose metabolism, likely via its' effects on body composition. The permutations of associations seen with TES and EFT to body composition (inverse associations to WC and %BF) and to CV risk factors (inverse associations to glucose and CHOL/HDL) together all lead toward a less than optimal health profile. This is of particular concern as high fasting glucose, a higher CHOL/HDL ratio, and greater deposition of central adiposity are risk factors for obesity, CVD, diabetes, and the development of the metabolic syndrome.

Upon further examination of our results, we found that 4.2% of our participants had the metabolic syndrome as defined by the National Cholesterol Education Program-Adult Treatment Panel III ([@B49]). SHBG concentrations of participants with the metabolic syndrome were lower than those without \[3.00 ± 0.42 *vs.* 3.48 ± 0.36 nmol^.^L^-1^; *t~(*823*)~* = 7.464, *p* \< 0.001\]. In a study by [@B6], although they did not include data on fasting glucose concentration, 17.1% of their sample met the criteria for the metabolic syndrome. Their results also demonstrated that participants with the metabolic syndrome had statistically significant lower SHBG concentrations than those without. They primarily advocated the role of SHBG in the hormonal regulation of the lipid profile. In accordance with the theories presented by [@B6], the present study also found that along with a lower concentration of basal SHBG, participants with the metabolic syndrome also had significantly lower TES and EFT concentrations, while COR was non-significant between groups.

Resting HR was inversely associated with TES and EFT, while an inverse relationship was demonstrated between SBP and SHBG. Previous studies have shown the same relationship in BP to SHBG ([@B27]; [@B48]; [@B63]). Our study did not show an association of TES with SBP nor DBP. This was also evident in a meta-analysis where no effect on SBP or DBP was shown with TES supplementation in 59 randomized controlled trials evaluating various populations ([@B12]). Most studies examining hormones and CV factors have predominantly focused on BP and less on HR. The mechanisms by which TES and EFT function to have an effect on resting HR needs to be further studied at the physiological level. TES has anti-hypertensive effects that may be a direct mechanism by modulating blood vessel resistance and arterial blood flow ([@B63]).

We observed positive associations for CV risk factors and COR to resting HR and SBP. This may indicate that higher basal COR concentration has an adverse association with HR and SBP. However, any observed association of COR remains complex due to its metabolic clearance rate, as well as its rate of production ([@B74]). Therefore, even the modest relationships with COR observed in the present study should be considered with caution. Nonetheless, similar results have previously been reported, although this was in individuals with CVD, CAD or SBP \> 160 mmHg ([@B67]; [@B18]; [@B52]). The present results indicate that although the contribution of elevated COR concentrations to resting HR and SBP is more pronounced in hypertensive individuals, a relationship exists in apparently healthy individuals as well. This may prove to be an additional risk factor for development of future CV health problems, although whether COR concentrations are causative or concurrent with HR and SBP is not evident.

TES, EFT, SHBG, and COR were associated with relative, but not with absolute (except SHBG) physical fitness variables. Interestingly, TES and EFT showed associations with aerobic (VO~2peak~) and short-duration anaerobic (6-s agility run) activities, but not with isometric maximal strength or muscular endurance measures (see **Table [4](#T4){ref-type="table"}**). Attenuated TES concentration has previously been evidenced in highly endurance-trained men ([@B31], [@B29], [@B28]; [@B14]), and in untrained men as a result of endurance training ([@B76]). However, some studies have not observed this diminution ([@B17]; [@B30]; [@B44]). The absence of the expected TES response in these latter studies was attributed to either the initial physical condition of the participants or the type of training stimulus. The present study sample was not analogous to either of these groups. It seems that lower basal TES concentration does not suggest an inherent potential for aerobic capacity performance, indicating that it may be the high volume of aerobic training that causes a reduction in basal TES. Thus, TES and EFT as such, may not pre-determine the trainability status of endurance capacity, though high concentrations of TES and EFT can be beneficial for muscle mass, strength and power development during training in both men (e.g., [@B34]) and, especially in women (e.g., [@B35]). Moreover, it has been previously reported ([@B11]) that faster running speed (*r* = 0.47) and greater power performance (maximal vertical jump, *r* = 0.43) were correlated with higher basal TES in similarly trained athletes. It has been documented in animal studies that TES is partly responsible for the development of fast twitch type II muscle fibers ([@B45]; [@B16]; [@B11]; [@B75]). While the present study demonstrated that agility run time was significantly faster in men with higher basal TES and EFT concentration, possibly due to a greater number or recruitment of fast twitch type II muscle fibers, the specificity of any detailed mechanisms were not examined.

Conclusion
==========

Higher concentrations of serum basal endogenous TES, EFT, and SHBG were associated with healthier body composition, fewer CV risks and greater maximal aerobic capacity (in relation to body mass) in healthy young adult men. In the future, it would be interesting to investigate whether the present relationships are still evident after a few decades. Additionally, whether chronic training over the years might lead to changes in the present relationships, and how different training modes (endurance, strength or their combination) positively affect physical fitness, body composition and their regulatory mechanisms over the decades.
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%BF

:   body fat percentage

BeP~max~

:   maximal bilateral bench press

BIA

:   bioelectrical impedance analysis

BMI

:   body mass index

BP

:   blood pressure

CAD

:   coronary artery disease

CHOL

:   total cholesterol

CHOL/HDL

:   total cholesterol to high density lipoprotein ratio

COR

:   cortisol

CV

:   cardiovascular

CVD

:   cardiovascular disease

DBP

:   diastolic blood pressure

EFT

:   empirical free testosterone

FFM

:   fat free mass

FM

:   fat mass

HDL

:   high density lipoprotein

HR

:   heart rate

LDL

:   low density lipoprotein

LP~max~

:   maximal bilateral leg press

relLP~max~

:   relative maximal bilateral leg press

relBeP~max~

:   relative maximal bilateral bench press

relVO~2peak~

:   relative estimated peak oxygen uptake

SBP

:   systolic blood pressure

SHBG

:   sex hormone-binding globulin

TES

:   testosterone

VO~2peak~

:   estimated peak oxygen uptake

WC

:   waist circumference
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